A video summary of the most important data regarding abiraterone (Zytiga ®) and enzalutamide (MDV-3100) - two of the most important new drugs in prostate cancer. Recorded at ASCO 2012.
To put a smile on your face see Larry's latest cartoon.
To learn more about clinical trials, take a look at our book.
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhAWYLVuUlu5Hq_Elg9pokI-Be5GFY8oe53iScn-8JSTfiAIDtmH6i7dl2al8n7es8vR4Jrb8RyXqdlAqt7geKEY8xbO2ZNy40uOc2nmpEwmUZCXPS2FRWvU4tlD8aTLWiV4kD8dX6S0Kg/s1600/WRITERS.jpg)
(c) 2012 Tom Beer and Larry Axmaker
No comments:
Post a Comment